Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 19 checked references that resolve
resolves10.1101/2021.09.01.21262955Immune response elicited from heterologous SARS-CoV-2 vaccination: Sinovac (CoronaVac) followed by AstraZeneca (Vaxzevria)
resolves10.4161/hv.25750DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus
resolves10.21203/rs.3.rs-1124837/v1The immunogenicity and safety of different COVID-19 booster vaccination following CoronaVac or ChAdOx1 nCoV-19 primary series
resolves10.1080/21645515.2022.2029111Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study
resolves10.1080/22221751.2021.1957401Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine
resolves10.1101/2021.07.10.21260232SARS-CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patients
resolves10.1101/2021.07.26.21261130Vaccine effectiveness when combining the ChAdOx1 vaccine as the first dose with an mRNA COVID-19 vaccine as the second dose
resolves10.1016/j.vaccine.2021.09.052A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia
resolves10.1016/S0140-6736(21)01694-9Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
resolves10.1101/2021.12.30.21268565Effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes
resolves10.1101/2021.11.03.21265791Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021
resolves10.1101/2022.01.17.22269415COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less immunity against omicron
The 12 references without a DOI — listed, not checked
no DOI — not checked(2021, July 05). India’s Coronavirus Death Toll Tops 400,000 as the Delta Variant Spreads Globally, Including in the United States—The Washington Post. Available online: https://www.washingtonpost.com/world/2021/07/02/coronavirus-latest-updates/.
no DOI — not checked(2021, May 16). Tracking SARS-CoV-2 Variants. Available online: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/.
no DOI — not checked(2021, August 16). COVID-19 Weekly Epidemiological Update, Edition 52, 10 August 2021. Available online: https://apps.who.int/iris/handle/10665/344062.
no DOI — not checked(2021, May 16). GISAID—Initiative. Available online: https://www.gisaid.org/.
no DOI — not checked(2021, July 05). AstraZeneca to Deliver Six Million COVID-19 Vaccine Doses in THAILAND. Available online: https://www.astrazeneca.com/country-sites/thailand/press-release/astrazeneca-to-deliver-six-million-covid-19-vaccine-doses-in-thailand.html.
no DOI — not checkedProduction, Titration, Neutralisation, Storage and Lyophilisation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lentiviral Pseudotypes
no DOI — not checked(2021, October 10). R: The R Project for Statistical Computing. Available online: https://www.r-project.org/.
no DOI — not checked(2021, October 10). RStudio—RStudio. Available online: https://www.rstudio.com/products/rstudio/.
no DOI — not checkedKassambara, A. (2021, October 10). Pipe-Friendly Framework for Basic Statistical. Available online: https://CRAN.R-project.org/package=rstatix.
no DOI — not checkedTakemori, T., Tarlinton, D., Hiepe, F., and Andreas, R.B. (2015). Cell Memory and Plasma Cell Development. Molecular Biology of B Cells, Elsevier Ltd.. [2nd ed.].
no DOI — not checkedJunker, D., Dulovic, A., Becker, M., Wagner, T.R., Laiser, P.D., Traenkle, B., Kienzle, K., Bunk, S., Struemper, C., and Haeberle, H. (2021). Reduced serum neutralization capacity against SARS-CoV-2 variants in a multiplex ACE2 RBD competition assay. medRxiv.
no DOI — not checked(2021, December 18). Interim Recommendations for Heterologous COVID-19 Vaccine Schedules. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE-recommendation-heterologous-schedules.
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.